Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality

Anumula, 1995, Rapid quantitative determination of sialic acids in glycoproteins by high-performance liquid chromatography with a sensitive fluorescence detection, Anal. Biochem., 230, 24, 10.1006/abio.1995.1432

Blomberg, 1996, Time-resolved fluorometric assay for natural killer activity using target cells labeled with a fluorescence enhancing ligand, J. Immunol. Meth., 193, 199, 10.1016/0022-1759(96)00063-4

Boyd, 1995, The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H, Mol. Immunol., 32, 1311, 10.1016/0161-5890(95)00118-2

Cartron, 2002, Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene, Blood, 99, 754, 10.1182/blood.V99.3.754

Deisenhofer, 1981, Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution, Biochemistry, 20, 2361, 10.1021/bi00512a001

Dijstelbloem, 2001, Inflammation in autoimmunity: receptors for IgG revisted, Trends Immunol., 22, 510, 10.1016/S1471-4906(01)02014-2

Ferrara, 2006, The carbohydrate at FcγRIIIa Asn-162: an element required for high affinity binding to non-fucosylated IgG glycoforms, J. Biol. Chem., 281, 5032, 10.1074/jbc.M510171200

Fleit, 1982, Human neutrophil Fc gamma receptor distribution and structure, Proc. Natl. Acad. Sci. U.S.A., 79, 3275, 10.1073/pnas.79.10.3275

Hodoniczky, 2005, Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro, Biotechnol. Prog., 21, 1644, 10.1021/bp050228w

Huber, 1976, Crystallographic structure studies of an IgG molecule and an Fc fragment, Nature, 264, 415, 10.1038/264415a0

Jassal, 2001, Sialylation of human IgG-Fc carbohydrate by transfected rat α2,6-sialyltransferase, Biochem. Biophys. Res. Commun., 286, 243, 10.1006/bbrc.2001.5382

Jefferis, 2005, Glycosylation of recombinant antibody therapeutics, Biotechnol. Prog., 21, 11, 10.1021/bp040016j

Kaneko, 2006, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, 313, 670, 10.1126/science.1129594

Knight, 1993, Construction and initial characterization of a mouse–human chimeric anti-TNF antibody, Mol. Immunol., 30, 1443, 10.1016/0161-5890(93)90106-L

Krapp, 2003, Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity, J. Mol. Biol., 325, 979, 10.1016/S0022-2836(02)01250-0

Kumpel, 1994, Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity, Hum. Antibod. Hybrid., 5, 143

Leatherbarrow, 1985, Effector functions of monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human Fc receptor, Mol. Immunol., 22, 407, 10.1016/0161-5890(85)90125-7

Lund, 1996, Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fcγ receptor I and influence the synthesis of its oligosaccharide chains, J. Immunol., 157, 4963, 10.4049/jimmunol.157.11.4963

Mimura, 2000, The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms, Mol. Immunol., 37, 697, 10.1016/S0161-5890(00)00105-X

Nose, 1983, Biological significance of carbohydrate chains on monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A., 80, 6632, 10.1073/pnas.80.21.6632

Papac, 1996, Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Anal. Chem., 68, 3215, 10.1021/ac960324z

Papac, 1998, A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis, Glycobiology, 8, 445, 10.1093/glycob/8.5.445

Raju, 2003, Glycosylation variations with expression systems, BioProcess Int., 1, 44

Raju, 2001, Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues, Biochemistry, 40, 8868, 10.1021/bi010475i

Raju, 2000, Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics, Glycobiology, 10, 477, 10.1093/glycob/10.5.477

Raju, 1994, Role of sialic acid on the viscosity of canine tracheal mucin glycoprotein, Biochem. Biophys. Res. Commun., 205, 402, 10.1006/bbrc.1994.2679

Raju, 2006, Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain, Biochem. Biophys. Res. Commun., 341, 797, 10.1016/j.bbrc.2006.01.030

2001, vol. 1

Shields, 2003, Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity, J. Biol. Chem., 277, 26733, 10.1074/jbc.M202069200

Shinkawa, 2003, The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity, J. Biol. Chem., 278, 3466, 10.1074/jbc.M210665200

Sondermann, 2001, Molecular basis of immune complex recognition: a comparison of Fc-receptor structures, J. Mol. Biol., 309, 737, 10.1006/jmbi.2001.4670

Tao, 1989, Studies of aglycosylated chimeric mouse–human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region, J. Immunol., 143, 2595, 10.4049/jimmunol.143.8.2595

Umaña, 1999, Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity, Nat. Biotech., 17, 176, 10.1038/6179

Varki, 1984, The release and purification of sialic acids from glycoconjugates: methods to minimize the loss and migration of O-acetyl groups, Anal. Biochem., 137, 236, 10.1016/0003-2697(84)90377-4

Wright, 1998, Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse–human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells, J. Immunol., 160, 3393, 10.4049/jimmunol.160.7.3393

Yamane-Ohnuki, 2004, Establishment of FUT8 knockout Chinese Hamster Ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity, Biotech. Bioeng., 87, 614, 10.1002/bit.20151